Skip to product information
1 of 1

BT Lab

SKU:BT-MCA0486

EphA7 Monoclonal Antibody

EphA7 Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants.

Introducing the EPHA7 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of molecular research. This meticulously crafted antibody is specifically engineered to target and bind to the EPHA7 protein, a crucial component in cellular signaling pathways.

The EPHA7 Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and reliable detection of EPHA7 protein expression in various biological samples. Its high sensitivity enables researchers to accurately quantify the levels of EPHA7, facilitating comprehensive investigations into its functional roles and potential therapeutic applications.

With its advanced formulation, this antibody guarantees optimal performance across a wide range of experimental techniques, including Western blotting, immunohistochemistry, and flow cytometry. Its versatility allows for seamless integration into diverse research protocols, empowering scientists to explore the intricate mechanisms underlying cellular processes.

Furthermore, the EPHA7 Monoclonal Antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. This ensures consistent batch-to-batch reproducibility, minimizing experimental variability and enhancing data reliability. Its long shelf life and stability further contribute to its reliability and cost-effectiveness.

In summary, the EPHA7 Monoclonal Antibody represents a breakthrough in molecular research, offering researchers an invaluable tool to unravel the complexities of EPHA7-mediated signaling pathways. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to accelerate scientific discoveries and pave the way for novel therapeutic interventions.

View full details